10 Results for "

REV7

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "REV7" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-126214
CAS No.: 1361227-90-8
Purity:  99.87%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

JH-RE-06, a potent REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POLζ. JH-RE-06 improves chemotherapy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100468
CAS No.: 1979192-13-6
Purity:  99.14%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71540
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MAD2L1; Mitotic Arrest Deficient 2-Like Protein 1; Mitotic Arrest Deficient 2 Like 1; MAD2-Like Protein 1; MAD2; Mitotic Arrest Deficient, Yeast, Homolog-Like 1; HSMAD2; MAD2 Mitotic Arrest Deficient-Like 1; MAD2 (Mitotic Arrest Deficient, Yeast, Homolog)
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-126214S
Purity:  98.04%
JH-RE-06-d6 is deuterium labele JH-RE-06. JH-RE-06, a potent REV1-REV7 interface inhibitor (IC50=0.78 μM; Ki=0.42 μM), targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POLζ. JH-RE-06 improves chemotherapy .
loading...
    loading...
Cat. No.: HY-100468R
CAS No.: 1979192-13-6
Research Areas:  

Cancer

REV7/REV3L-IN-1 (Standard) is the analytical standard of REV7/REV3L-IN-1 (HY-100468). This product is intended for research and analytical applications. REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research .
loading...
    loading...
Cat. No.: HY-P83445
Synonyms: REV7; FANCV; MAD2B; POLZ2

Host:  

Rabbit

Application:  

WB, ICC/IF, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83445A
Synonyms: REV7; FANCV; MAD2B; POLZ2

Host:  

Rabbit

Application:  

WB, ICC/IF, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-RS07951
Research Areas:  

Others

MAD2L2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAD2L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19788
Research Areas:  

Others

Mad2l2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mad2l2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P810361
Synonyms: Homolog of REV7 S ceREVisiae, hREV7, MAD2 (mitotic arrest deficient yeast, homolog) like 2, MAD2 homolog, MAD2 like 2, MAD2 mitotic arrest deficient like 2, MAD2-like protein 2, MAD2B, Mad2l2, MD2L2_HUMAN

Host:  

Rabbit

Application:  

WB, IHC-P, FC, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...